Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2021.638001
Abstract: Objective: Switching between second-generation antipsychotics (SGAs) is a common clinical practice in the treatment of schizophrenia and schizoaffective disorders due to differences in the drugs’ tolerability and safety profiles as well as the challenge of…
read more here.
Keywords:
schizoaffective disorder;
switching second;
schizophrenia schizoaffective;
second generation ... See more keywords